OPKO Health Quarterly Cash Flow Statement
NASDAQ: OPKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 12, 4:00 PM ET · Delayed 15 min
OPKO Health free cash flow
In the quarter ended Jun 30, 2026, OPKO Health generated -$43.5 million of operating cash flow and spent $3.0 million on capital expenditures. That left free cash flow of -$46.5 million, a free-cash-flow margin of -28.4% of revenue. OPKO Health returned $13.0 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
OPKO Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -8.42M | -54.85M | -31.26M | 21.63M | -148.44M | -67.61M | 14.03M | 24.89M | -10.30M | -81.84M | -66.48M | -84.47M |
| Net Income growth (YoY) | — | — | -322.83% | -13.09% | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 22.41M | 22.20M | 22.37M | 22.74M | 23.03M | 23.49M | 24.04M | 24.16M | 24.16M | 25.82M | 25.98M | 26.18M |
| Stock-Based Compensation | 2.20M | 2.73M | 2.92M | 3.00M | 2.20M | 2.62M | 3.06M | 2.80M | 2.60M | 2.59M | 2.67M | 3.20M |
| Change in Working Capital | 5.65M | 13.09M | -9.06M | 181.00K | -7.22M | 28.00M | -32.60M | 30.46M | 16.07M | 14.59M | 12.04M | 69.75M |
| Operating Cash Flow | -43.50M | -19.31M | -25.92M | -34.65M | -83.42M | -34.55M | -44.41M | -77.08M | -26.43M | -35.57M | -38.29M | 33.11M |
| Capital Expenditures | -3.00M | -1.83M | -2.67M | -3.13M | -3.28M | -3.19M | -5.41M | -7.94M | -7.22M | -4.44M | -3.02M | -4.20M |
| Investing Cash Flow | 15.54M | -1.80M | -2.05M | 194.65M | -2.83M | 40.53M | 115.99M | 247.78M | -7.16M | -4.39M | -1.42M | -3.57M |
| Share Repurchases | -13.02M | -4.77M | -13.51M | -15.28M | -18.25M | 0 | -16.46M | -23.76M | 0 | -50.00M | 0 | 0 |
| Debt Issued | — | — | 0 | — | — | — | 0 | — | — | — | 0 | — |
| Debt Repaid | — | — | — | — | — | -174.00K | 0 | 0 | 0 | -146.29M | 0 | 0 |
| Financing Cash Flow | -13.03M | -5.16M | -18.34M | -16.21M | -79.49M | -4.02M | -40.47M | 206.14M | -2.12M | 20.61M | -3.75M | 2.10M |
| Net Change in Cash | -41.13M | -27.18M | -46.13M | 143.48M | -164.28M | 4.06M | 25.55M | 379.49M | -35.06M | -20.24M | -42.74M | 30.51M |
| Free Cash Flow | -46.50M | -21.14M | -28.59M | -37.78M | -86.70M | -37.75M | -49.82M | -85.02M | -33.65M | -40.01M | -41.32M | 28.91M |
This table shows 12 quarterly periods of OPKO Health's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OPK's reporting calendar. What is a cash flow statement?